Antigen-specific interferon-gamma responses and innate cytokine balance in TB-IRIS

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Goovaerts, Odin ^a,b   Jennes, Wim ^a   Massinga Loembé, Marguerite ^a,c,d   Ceulemans, Ann ^a   Worodria, William ^e,f   Mayanja Kizza, Harriet ^e   Colebunders, Robert ^a,b   Kestens, Luc ^a,b  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c ALBERT SCHWEITZER HOSPITAL   (Gabon)

^d Institut für Tropenmedizin Universitä T Tu Bingen   (Germany)

^e MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^f Infectious Diseases Network for Treatment and Research in Africa INTERACT   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; TUBERCULIN; TUBERCULOSIS ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS ANTIGEN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CYTOKINE; IL12RB2 PROTEIN, HUMAN; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; TUBERCULOSTATIC AGENT;

ADULT; ANTIGEN SPECIFICITY; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IN VITRO STUDY; INFLUENZA; INNATE IMMUNITY; MALE; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; PATHOGENESIS; PROSPECTIVE STUDY; TUBERCULOSIS; TUBERCULOSIS ASSOCIATED IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; COMPLICATION; CYTOMEGALOVIRUS INFECTION; HIV INFECTIONS; IMMUNOLOGY; METABOLISM;

ADULT; ANTI-HIV AGENTS; ANTIGENS, BACTERIAL; ANTITUBERCULAR AGENTS; CD4 LYMPHOCYTE COUNT; CYTOKINES; CYTOMEGALOVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INFLUENZA, HUMAN; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; RECEPTORS, INTERLEUKIN-12; TUBERCULOSIS;

EID: 84912001620     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113101     Document Type: Article

References (54)

1. Sharma SK, Mohan A, Kadhiravan T (2005) HIV-TB co-infection: epidemiology, diagnosis & management. Indian J Med Res 121: 550-567.
2. Getahun H, Gunneberg C, Granich R, Nunn P (2010) HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis 50 Suppl 3:: S201-S207. 10.1086/651492 [doi].
3. WHO (2013) Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection.
4. Kigozi IM, Dobkin LM, Martin JN, Geng EH, Muyindike W, et al. (2009) Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. J Acquir Immune Defic Syndr 52: 280-289. 10.1097/QAI.0b013e3181ab6eab [doi].
5. Meintjes G, Lawn SD, Scano F, Maartens G, French MA, et al. (2008) Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 8: 516-523.
6. Muller M, Wandel S, Colebunders R, Attia S, Furrer H, et al. (2010) Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 10: 251-261. S1473-3099(10)70026-8 [pii]; 10.1016/S1473- 3099(10)70026-8 [doi].
7. Murdoch DM, Venter WD, Van Rie A, Feldman C (2007) Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther 4: 9. 1742-6405-4-9 [pii]; 10.1186/1742-6405-4-9 [doi].
8. Worodria W, Conesa-Botella A, Kisembo H, McAdam KP, Colebunders R (2009) Coping with TB immune reconstitution inflammatory syndrome. Expert Review of Respiratory Medicine 3: 147-152.
9. Conesa-Botella A, Loembe MM, Manabe YC, Worodria W, Mazakpwe D, et al. (2011) Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome. J Acquir Immune Defic Syndr. 10.1097/QAI.0b013e31823801de [doi].
10. Worodria W, Massinga-Loembe M, Mazakpwe D, Luzinda K, Menten J, et al. (2011) Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy. J Acquir Immune Defic Syndr 58: 32-37. 10.1097/QAI.0b013e3182255dc2 [doi].
11. Barber DL, Andrade BB, Sereti I, Sher A (2012) Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none. Nat Rev Microbiol 10: 150-156. nrmicro2712 [pii]; 10.1038/ nrmicro2712 [doi].
12. Wilson EM, Sereti I (2013) Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs. Immunol Rev 254: 343-354. 10.1111/imr.12064 [doi].
13. French MA (2007) Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy. Curr HIV/AIDS Rep 4: 16-21.
14. Bourgarit A, Carcelain G, Martinez V, Lascoux C, Delcey V, et al. (2006) Explosion of tuberculinspecific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS 20: F1-F7. 10.1097/01.aids.0000202648.18526.bf [doi]; 00002030-200601090-00001 [pii].
15. Tan DB, Yong YK, Tan HY, Kamarulzaman A, Tan LH, et al. (2008) Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis. HIV Med 9: 307-316.
16. Tan DB, Lim A, Yong YK, Ponnampalavanar S, Omar S, et al. (2011) TLR2-induced cytokine responses may characterize HIV-infected patients experiencing mycobacterial immune restoration disease. AIDS 25: 1455-1460. 10.1097/QAD.0b013e328348fb18 [doi].
17. Narita M, Ashkin D, Hollender ES, Pitchenik AE (1998) Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 158: 157-161.
18. Vignesh R, Kumarasamy N, Lim A, Solomon S, Murugavel KG, et al. (2013) TB-IRIS After Initiation of Antiretroviral Therapy Is Associated With Expansion of Preexistent Th1 Responses Against Mycobacterium tuberculosis Antigens. J Acquir Immune Defic Syndr 64: 241-248. 10.1097/ QAI.0b013e31829f6df2 [doi].
19. Meintjes G, Wilkinson KA, Rangaka MX, Skolimowska K, van Veen K, et al. (2008) Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome. Am J Respir Crit Care Med 178: 1083-1089.
20. Elliott JH, Vohith K, Saramony S, Savuth C, Dara C, et al. (2009) Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy. J Infect Dis 200: 1736-1745. 10.1086/644784 [doi].
21. Tieu HV, Ananworanich J, Avihingsanon A, Apateerapong W, Sirivichayakul S, et al. (2009) Immunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in Thailand. AIDS Res Hum Retroviruses 25: 1083-1089. 10.1089/aid.2009.0055 [doi].
22. Oliver BG, Elliott JH, Price P, Phillips M, Saphonn V, et al. (2010) Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy. J Infect Dis 202: 1728-1737. 10.1086/ 657082 [doi].
23. Grant PM, Komarow L, Lederman MM, Pahwa S, Zolopa AR, et al. (2012) Elevated Interleukin 8 and T-Helper 1 and T-Helper 17 Cytokine Levels Prior to Antiretroviral Therapy in Participants Who Developed Immune Reconstitution Inflammatory Syndrome During ACTG A5164. J Infect Dis. jis604 [pii]; 10.1093/infdis/jis604 [doi].
24. Conesa-Botella A, Meintjes G, Coussens AK, van der Plas H, Goliath R, et al. (2012) Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-TB immune reconstitution inflammatory syndrome (TB-IRIS). Clin Infect Dis. cis577 [pii]; 10.1093/cid/cis577 [doi].
25. Tadokera R, Meintjes G, Skolimowska KH, Wilkinson KA, Matthews K, et al. (2011) Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome. Eur Respir J 37: 1248-1259. 09031936.00091010 [pii]; 10.1183/09031936.00091010 [doi].
26. Goovaerts O, JennesW, Massinga-Loembe M, Ceulemans A, Worodria W, et al. (2013) LPS-binding protein and IL-6 mark paradoxical tuberculosis immune reconstitution inflammatory syndrome in HIV patients. PLoS One 8: e81856. 10.1371/journal.pone.0081856 [doi]; PONE-D-13-33780 [pii].
27. Fukuda T, Matsumura T, Ato M, Hamasaki M, Nishiuchi Y, et al. (2013) Critical roles for lipomannan and lipoarabinomannan in cell wall integrity of mycobacteria and pathogenesis of tuberculosis. MBio 4: e00472-12. mBio.00472-12 [pii]; 10.1128/mBio.00472-12 [doi].
28. Worodria W, Massinga-Loembe M, Mayanja-Kizza H, Namaganda J, Kambugu A, et al. (2011) Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART. Clin Dev Immunol 2011: 758350. 10.1155/2011/758350 [doi].
29. Worodria W, Menten J, Massinga-Loembe M, Mazakpwe D, Bagenda D, et al. (2012) Clinical spectrum, risk factors and outcome of immune reconstitution inflammatory syndrome in patients with tuberculosis-HIV coinfection. Antivir Ther. 10.3851/IMP2108 [doi].
30. World Health Organisation (WHO) (2012) Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents. Recommendations for HIVprevalent and resource-contstrained settings.
31. Streiner DL, Norman GR (2011) Correction for multiple testing: is there a resolution? Chest 140: 16-18. 140/1/16 [pii]; 10.1378/chest.11-0523 [doi].
32. Perneger TV (1998) What's wrong with Bonferroni adjustments. BMJ 316: 1236-1238.
33. Antoniades CG, Berry PA, Wendon JA, Vergani D (2008) The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol 49: 845-861. S0168-8278(08)00506-0 [pii]; 10.1016/j.jhep.2008.08.009 [doi].
34. Taniguchi T, Koido Y, Aiboshi J, Yamashita T, Suzaki S, et al. (1999) Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 27: 1262-1264.
35. van Dissel JT, van Langevelde P, Westendorp RG, Kwappenberg K, Frolich M (1998) Antiinflammatory cytokine profile and mortality in febrile patients. Lancet 351: 950-953. S0140- 6736(05)60606-X [pii]; 10.1016/S0140-6736(05)60606-X [doi].
36. Gogos CA, Drosou E, Bassaris HP, Skoutelis A (2000) Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 181: 176-180. JID990857 [pii]; 10.1086/315214 [doi].
37. Walley KR, Lukacs NW, Standiford TJ, Strieter RM, Kunkel SL (1996) Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun 64: 4733-4738.
38. Millington KA, Innes JA, Hackforth S, Hinks TS, Deeks JJ, et al. (2007) Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol 178: 5217-5226. 178/8/5217 [pii].
39. Aiken AM, Hill PC, Fox A, McAdam KP, Jackson-Sillah D, et al. (2006) Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis 6: 66. 1471-2334-6-66 [pii]; 10.1186/ 1471-2334-6-66 [doi].
40. Karam F, Mbow F, Fletcher H, Senghor CS, Coulibaly KD, et al. (2008) Sensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression. PLoS One 3: e1441. 10.1371/journal.pone.0001441 [doi].
41. Antonelli LR, Mahnke Y, Hodge JN, Porter BO, Barber DL, et al. (2010) Elevated frequencies of highly activated CD4+ Tcells in HIV+ patients developing immune reconstitution inflammatory syndrome. Blood 116: 3818-3827. blood-2010-05-285080 [pii]; 10.1182/blood-2010-05-285080 [doi].
42. Lawn SD, Bekker LG, Miller RF (2005) Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 5: 361-373.
43. Boulware DR, Meya DB, Bergemann TL, Wiesner DL, Rhein J, et al. (2010) Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. PLoS Med 7: e1000384. 10.1371/journal.pmed.1000384 [doi].
44. Beishuizen SJ, Geerlings SE (2009) Immune reconstitution inflammatory syndrome: immunopathogenesis, risk factors, diagnosis, treatment and prevention. Neth J Med 67: 327-331.
45. Tran HT, Van Den Bergh R, Vu TN, Laukens K, Worodria W, et al. (2014) The role of monocytes in the development of Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome. Immunobiology 219: 37-44. S0171-2985(13)00139-3 [pii]; 10.1016/j.imbio.2013.07.004 [doi].
46. Le J, Lin JX, Henriksen-DeStefano D, Vilcek J (1986) Bacterial lipopolysaccharide-induced interferongamma production: roles of interleukin 1 and interleukin 2. J Immunol 136: 4525-4530.
47. Raices RM, Kannan Y, Sarkar A, Bellamkonda-Athmaram V, Wewers MD (2008) A synergistic role for IL-1beta and TNFalpha in monocyte-derived IFNgamma inducing activity. Cytokine 44: 234-241. S1043- 4666(08)00687-X [pii]; 10.1016/j.cyto.2008.08.004 [doi].
48. Pulliam L, Sun B, Rempel H (2004) Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load. J Neuroimmunol 157: 93-98. S0165-5728(04)00338-8 [pii]; 10.1016/ j.jneuroim.2004.08.039 [doi].
49. Dudhane A, Conti B, Orlikowsky T, Wang ZQ, Mangla N, et al. (1996) Monocytes in HIV type 1- infected individuals lose expression of costimulatory B7 molecules and acquire cytotoxic activity. AIDS Res Hum Retroviruses 12: 885-892.
50. Van Den Bergh R, Vanham G, Raes G, De Baetselier P., Colebunders R (2006) Mycobacteriumassociated immune reconstitution disease: macrophages running wild? Lancet Infect Dis 6: 2-3.
51. Gompels UA, Larke N, Sanz-Ramos M, Bates M, Musonda K, et al. (2012) Human cytomegalovirus infant infection adversely affects growth and development in maternally HIV-exposed and unexposed infants in Zambia. Clin Infect Dis 54: 434-442. cir837 [pii]; 10.1093/cid/cir837 [doi].
52. Njeru DG, Mwanda WO, Kitonyi GW, Njagi EC (2009) Prevalence of cytomegalovirus antibodies in blood donors at the National Blood Transfusion Centre, Nairobi. East Afr Med J 86: S58-S61.
53. World Health Organisation (WHO) (2011) Influenza update.
54. Byarugaba DK, Ducatez MF, Erima B, Mworozi EA, Millard M, et al. (2011) Molecular epidemiology of influenza A/H3N2 viruses circulating in Uganda. PLoS One 6: e27803. 10.1371/journal.pone.0027803 [doi]; PONE-D-11-06928 [pii].